Home General Physiology and Biophysics 2018 General Physiology and Biophysics Vol.37, No.5, p.495–514, 2018

Journal info

Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

General Physiology and Biophysics Vol.37, No.5, p.495–514, 2018

Title: miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives
Author: N. Kosikova, M. Cente, V. Cigankova, P. Koson, P. Filipcik

Abstract: After many decades of research in the field of neurodegeneration, we have no effective cure for Alzheimer’s disease (AD), a major form of dementia. It is mainly due to the lack of early, reliable and sensitive biomarkers and incomplete understanding of disease mechanisms at molecular level. Several recently employed biomarkers, especially their combinations, can discriminate advanced stages of AD from other forms of dementia or neuropathy. They do not provide much information on molecular mechanisms of disease, rather they reflect the amount of key histopathological markers in the diseased brain. This review is focussed on novel class of potentially very promising AD biomarkers: extracellular miRNAs in body liquids, such as cerebrospinal fluid and blood. Those have a great potential not only to indicate the presence of AD, but more importantly, to reflect the molecular mechanisms playing a role early at the beginning of the pathogenic pathways consequently leading to AD. We believe this comprehensive review on deregulated miRNAs in AD can be a good source of information for thorough in silico analyses aiming to identify, develop and validate of miRNAs as “diseases mechanism engaged” candidate biomarkers. Having such molecules could bring us closer to the goal – successful treatment of AD.

Keywords: Alzheimer’s disease, miRNA, Biomarker, Diagnostics, Cerebrospinal fluid, Blood
Published online: 02-Oct-2018
Year: 2018, Volume: 37, Issue: 5 Page From: 495, Page To: 514

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.